November 07, 2023
The nation continues to grapple with shortages of nearly 130 over-the-counter and prescription medications, including Adderall, amoxicillin, and certain cancer treatments that have been in short supply this year.
The shortages have prompted a response from the Drug Enforcement Administration (DEA) and federal lawmakers as they look to address the causes of the supply issue. In a letter to the public last week, DEA Administrator Anne Milgram said the agency continues to take action to understand the shortage.
"As we said in our prior letter, there are still important issues that will need to be addressed through longer-term coordination by DEA, FDA, drug manufacturers, and other stakeholders to resolve these issues in the long term,” Milgram said.
Here’s what you need to know:
HAP continues to monitor the drug supply shortages and provide updates to members.
The House Oversight Committee and DEA letters are available online.
Tags: Public Health | Federal Advocacy | Affordable Prescription Drugs
Click on topic below for category-specific news articles.
Related Links